Pathogenesis of SARS-CoV-2 Infection

 Saturday, May 7, 2022     10:15 AM – 12:15 PM ET     Oregon Ballroom 202

Pathogenesis of SARS-CoV-2 Infection

Chairs

• Amelia Pinto, Saint Louis Univ. Sch. of Med.
• Majid Kazemian, Purdue Univ.

Speakers

• Elizabeth Geerling, St. Louis Univ., Sch. of Med., Metabolic syndrome enhances viral disease severity and reduces vaccine efficacy in mice
• Jian Zheng, Univ. of Iowa, Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19
• Stephen T. Yeung, Weill Cornell Grad. Sch. of Med. Sci., Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 Infection
• Bingyu Yan, Purdue Univ., SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
• Ksenia Rybkina, Columbia Univ. Med. Ctr., Children with Multi-System Inflammatory Syndrome (MIS-C) develop functionally competent T cell memory against SARS-CoV-2 following recovery
• Zehra Rahman, Univ. at Buffalo Sch. of Med. and BioMed. Sci., Exploration of shared antibody motifs in Kawasaki Disease (KD) and COVID-19 related Multisystem Inflammatory Syndrome of Childhood (MIS-C)
• Brandi L. Clark, St. Jude Children’s Res. Hosp., Identifying distinct T cell subsets in the context of pediatric ARDS
• Yu Gao, Karolinska Inst., SARS-CoV-2 mRNA vaccination induces polyfunctional T cell responses in healthy and immunocompromised individuals